ATARA BIOTHERAPEUTICS, INC. Increase (Decrease) in Prepaid Expense and Other Assets
ATARA BIOTHERAPEUTICS, INC. (ATRA) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$169.00 thousand for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2023-08-08
- ATARA BIOTHERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2023-06-30 was -$2.75M, a 227.75% decline year-over-year.
- ATARA BIOTHERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2023-03-31 was $2.58M.
- ATARA BIOTHERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2022-09-30 was $2.36M.
- ATARA BIOTHERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2022-06-30 was $2.15M.
- ATARA BIOTHERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2021 was -$8.18M, a 194.41% decline from fiscal 2020.
- ATARA BIOTHERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2020 was $8.67M, a 768.34% increase from fiscal 2019.
- ATARA BIOTHERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2019 was $998.00K, a 82.69% decline from fiscal 2018.
- ATARA BIOTHERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2018 was $5.76M, a 635.20% increase from fiscal 2017.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 4 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|---|
| 2023-06-30 | -$2.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$169.00K 10-Q · filed 2023-08-08 | |||
| 2023-03-31 | $2.58M 10-Q · filed 2023-05-08 | ||||
| 2022-09-30 | $2.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $4.51M derived: sum of 2 quarters · filed 2023-08-08 | $3.90M 10-Q · filed 2022-11-08 | $6.56M derived: sum of 4 quarters · filed 2023-08-08 | |
| 2022-06-30 | $2.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $1.55M 10-Q · filed 2023-08-08 | $4.21M derived: sum of 3 quarters · filed 2023-08-08 | -$4.22M derived: sum of 4 quarters · filed 2023-08-08 | |
| 2022-03-31 | -$609.00K 10-Q · filed 2023-05-08 | $2.05M derived: sum of 2 quarters · filed 2023-05-08 | -$6.37M derived: sum of 3 quarters · filed 2023-05-08 | -$6.96M derived: sum of 4 quarters · filed 2023-05-08 | |
| 2021-12-31 | $2.66M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$5.76M derived: sum of 2 quarters · filed 2022-11-08 | -$6.35M derived: sum of 3 quarters · filed 2022-11-08 | -$8.18M 10-K · filed 2022-02-28 | |
| 2021-09-30 | -$8.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$9.01M derived: sum of 2 quarters · filed 2022-11-08 | -$10.84M 10-Q · filed 2022-11-08 | -$1.46M derived: sum of 4 quarters · filed 2022-11-08 | |
| 2021-06-30 | -$591.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$2.42M 10-Q · filed 2022-08-08 | $6.96M derived: sum of 3 quarters · filed 2022-08-08 | $7.67M derived: sum of 4 quarters · filed 2022-08-08 | |
| 2021-03-31 | -$1.83M 10-Q · filed 2022-05-05 | $7.55M derived: sum of 2 quarters · filed 2022-05-05 | $8.26M derived: sum of 3 quarters · filed 2022-05-05 | $4.95M derived: sum of 4 quarters · filed 2022-05-05 | |
| 2020-12-31 | $9.38M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $10.09M derived: sum of 2 quarters · filed 2022-02-28 | $6.78M derived: sum of 3 quarters · filed 2022-02-28 | $8.67M 10-K · filed 2022-02-28 | |
| 2020-09-30 | $706.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$2.60M derived: sum of 2 quarters · filed 2021-11-04 | -$717.00K 10-Q · filed 2021-11-04 | $1.49M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2020-06-30 | -$3.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$1.42M 10-Q · filed 2021-08-09 | $779.00K derived: sum of 3 quarters · filed 2022-02-28 | $295.00K derived: sum of 4 quarters · filed 2022-02-28 | |
| 2020-03-31 | $1.89M 10-Q · filed 2021-05-04 | $4.09M derived: sum of 2 quarters · filed 2022-02-28 | $3.61M derived: sum of 3 quarters · filed 2022-02-28 | $1.45M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2019-12-31 | $2.20M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $1.72M derived: sum of 2 quarters · filed 2022-02-28 | -$436.00K derived: sum of 3 quarters · filed 2022-02-28 | $998.00K 10-K · filed 2022-02-28 | |
| 2019-09-30 | -$484.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$2.64M derived: sum of 2 quarters · filed 2020-11-09 | -$1.20M 10-Q · filed 2020-11-09 | $2.22M derived: sum of 4 quarters · filed 2021-03-01 | |
| 2019-06-30 | -$2.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$720.00K 10-Q · filed 2020-08-05 | $2.71M derived: sum of 3 quarters · filed 2021-03-01 | $3.08M derived: sum of 4 quarters · filed 2021-03-01 | |
| 2019-03-31 | $1.43M 10-Q · filed 2020-05-06 | $4.86M derived: sum of 2 quarters · filed 2021-03-01 | $5.24M derived: sum of 3 quarters · filed 2021-03-01 | $7.01M derived: sum of 4 quarters · filed 2021-03-01 | |
| 2018-12-31 | $3.42M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $3.80M derived: sum of 2 quarters · filed 2021-03-01 | $5.58M derived: sum of 3 quarters · filed 2021-03-01 | $5.76M 10-K · filed 2021-03-01 | |
| 2018-09-30 | $378.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $2.15M derived: sum of 2 quarters · filed 2019-11-07 | $2.34M 10-Q · filed 2019-11-07 | $2.00M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-06-30 | $1.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $1.96M 10-Q · filed 2019-08-08 | $1.62M derived: sum of 3 quarters · filed 2020-02-27 | $2.02M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-03-31 | $189.00K 10-Q · filed 2019-05-09 | -$152.00K derived: sum of 2 quarters · filed 2020-02-27 | $248.00K derived: sum of 3 quarters · filed 2020-02-27 | $1.17M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2017-12-31 | -$341.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $59.00K derived: sum of 2 quarters · filed 2020-02-27 | $983.00K derived: sum of 3 quarters · filed 2020-02-27 | $784.00K 10-K · filed 2020-02-27 | |
| 2017-09-30 | $400.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $1.32M derived: sum of 2 quarters · filed 2018-11-06 | $1.13M 10-Q · filed 2018-11-06 | $1.26M derived: sum of 4 quarters · filed 2019-02-26 | |
| 2017-06-30 | $924.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $725.00K 10-Q · filed 2018-08-01 | $865.00K derived: sum of 3 quarters · filed 2019-02-26 | $651.00K derived: sum of 4 quarters · filed 2019-02-26 | |
| 2017-03-31 | -$199.00K 10-Q · filed 2018-05-08 | -$59.00K derived: sum of 2 quarters · filed 2019-02-26 | -$273.00K derived: sum of 3 quarters · filed 2019-02-26 | -$761.00K derived: sum of 4 quarters · filed 2019-02-26 | |
| 2016-12-31 | $140.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | -$74.00K derived: sum of 2 quarters · filed 2019-02-26 | -$562.00K derived: sum of 3 quarters · filed 2019-02-26 | $742.00K 10-K · filed 2019-02-26 | |
| 2016-09-30 | -$214.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$702.00K derived: sum of 2 quarters · filed 2017-11-09 | $602.00K 10-Q · filed 2017-11-09 | -$1.15M derived: sum of 4 quarters · filed 2018-02-27 | |
| 2016-06-30 | -$488.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $816.00K 10-Q · filed 2017-08-07 | -$931.00K derived: sum of 3 quarters · filed 2018-02-27 | -$1.73M derived: sum of 4 quarters · filed 2018-02-27 | |
| 2016-03-31 | $1.30M 10-Q · filed 2017-05-04 | -$443.00K derived: sum of 2 quarters · filed 2018-02-27 | -$1.24M derived: sum of 3 quarters · filed 2018-02-27 | $990.00K derived: sum of 4 quarters · filed 2018-02-27 | |
| 2015-12-31 | -$1.75M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$2.55M derived: sum of 2 quarters · filed 2018-02-27 | -$314.00K derived: sum of 3 quarters · filed 2018-02-27 | $767.00K 10-K · filed 2018-02-27 | |
| 2015-09-30 | -$800.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $1.43M derived: sum of 2 quarters · filed 2016-11-04 | $2.51M 10-Q · filed 2016-11-04 | $3.79M derived: sum of 4 quarters · filed 2017-03-09 | |
| 2015-06-30 | $2.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $3.31M 10-Q · filed 2016-08-08 | $4.59M derived: sum of 3 quarters · filed 2017-03-09 | $4.30M derived: sum of 4 quarters · filed 2017-03-09 | |
| 2015-03-31 | $1.08M 10-Q · filed 2016-05-06 | $2.36M derived: sum of 2 quarters · filed 2017-03-09 | $2.06M derived: sum of 3 quarters · filed 2017-03-09 | $2.37M derived: sum of 4 quarters · filed 2017-03-09 | |
| 2014-12-31 | $1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | $982.00K derived: sum of 2 quarters · filed 2017-03-09 | $1.29M derived: sum of 3 quarters · filed 2017-03-09 | $1.25M 10-K · filed 2017-03-09 | |
| 2014-09-30 | -$297.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $11.00K derived: sum of 2 quarters · filed 2015-11-06 | -$33.00K 10-Q · filed 2015-11-06 | -$398.00K derived: sum of 4 quarters · filed 2016-03-04 | |
| 2014-06-30 | $308.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $264.00K 10-Q · filed 2015-08-07 | -$101.00K derived: sum of 3 quarters · filed 2016-03-04 | ||
| 2014-03-31 | -$44.00K 10-Q · filed 2015-05-11 | -$409.00K derived: sum of 2 quarters · filed 2016-03-04 | |||
| 2013-12-31 | -$365.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-04 | $158.00K 10-K · filed 2016-03-04 | |||
| 2013-09-30 | $523.00K 10-Q · filed 2014-11-12 | ||||
| 2012-12-31 | $35.00K 10-K · filed 2015-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |